New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics
Research Funding Available for Preeclampsia and Related Pregnancy Disorders
North Bethesda, MD – February 10, 2024—The Foundation for the National Institutes of Health (FNIH) today announced the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset pree...
The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors. Robyn D’Oria, MA, RNC, APN will serve as the new Board chair.
Sponsors live webinar on October 19 with experts, patient advocates
The Preeclampsia Foundation announced today that the Centers for Disease Control and Prevention (CDC) awarded new funding for its MoMMA’s Voices program, a national coalition of patient advocacy organizations and individuals with "lived experience" –...
Abt Associates, together with subcontractors HealthBegins and the MoMMA’s Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appr...
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recipients. These highly competitive monetary awards re...
New preeclampsia research funded by Preeclampsia Foundation Peter J. Pappas grant finds distinct genetic traits of early-onset preeclampsia.
Preeclampsia survivors and their supporters will hit the pavement with a purpose on Saturday, August 26, as part of the fourth annual Promise Walk Wherever event sponsored by the Preeclampsia Foundation.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research for two, two-year grants of up to $200,000.
A new diagnostic test for preeclampsia has received approval from the US Food and Drug Administration for use in hospital settings.
The Preeclampsia Foundation is committed to transparency, the highest standards of financial accountability and appropriate stewardship of our resources.